(3-(Cyclopentyloxy)-5-(trifluoromethoxy)phenyl)boronic acid

Catalog No. :
ACZSPQ607
CAS No. :
1256346-04-9
Molecular Formula :
C12H14BF3O4
Molecular Weight :
290.05

IUPAC Name:(3-(cyclopentyloxy)-5-(trifluoromethoxy)phenyl)boronic acid

(3-(Cyclopentyloxy)-5-(trifluoromethoxy)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$117.00Login to see priceInquiryInquiry
1g97%$252.00Login to see priceInquiryInquiry
5g97%$717.00Login to see priceInquiryInquiry
10g97%$949.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3-(Cyclopentyloxy)-5-(trifluoromethoxy)phenyl)boronic acid
IUPAC Name(3-(cyclopentyloxy)-5-(trifluoromethoxy)phenyl)boronic acid
MDL No.MFCD16295065
Molecular FormulaC12H14BF3O4
Molecular Weight290.05
SMILESOB(O)C1=CC(OC2CCCC2)=CC(OC(F)(F)F)=C1
InChI KeyHPSHUTQIASVROT-UHFFFAOYSA-N
Synonym3-(Cyclopentyloxy)-5-(trifluoromethoxy)phenylboronic acid;Boronic acid, B-[3-(cyclopentyloxy)-5-(trifluoromethoxy)phenyl]-
CAS No.1256346-04-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZSPQ607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSPQ607 route product structure diagram
    ACZSPQ6071256346-04-9
Inquiry

2. ACZSPQ607 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSPQ607 route product structure diagram
    ACZSPQ6071256346-04-9
Inquiry

Comments (0)